• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $FRMM

    Forum Markets Incorporated

    Subscribe to $FRMM
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IPO Year: 2017

    Exchange: NASDAQ

    Recent Analyst Ratings for Forum Markets Incorporated

    DatePrice TargetRatingAnalyst
    4/7/2026$5.00Speculative Buy
    The Benchmark Company
    See more ratings

    Forum Markets Incorporated Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Forum Markets with a new price target

    The Benchmark Company initiated coverage of Forum Markets with a rating of Speculative Buy and set a new price target of $5.00

    4/7/26 8:46:27 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Lomashuk Konstantin claimed ownership of 1,487,389 shares (SEC Form 3)

    3 - FORUM MARKETS Inc (0001690080) (Issuer)

    5/12/26 4:44:24 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Dalton Angela

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/6/26 8:15:10 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Dalton Angela

    3 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/6/26 7:46:15 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Edwards Michael A

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:10:48 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Suckling Andrew P

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:10:11 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Smith Ryan Lewis

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:09:49 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Saunders John Tazewell

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:09:27 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Rudisill Mcandrew

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:09:07 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by New Jason Griffin

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:08:47 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Heter Crystal Jane

    4 - FORUM MARKETS Inc (0001690080) (Issuer)

    4/3/26 7:08:20 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated Press Releases

    Fastest customizable press release news feed in the world

    View All

    Forum Announces Initiation of Analyst Coverage by Sidoti & Company with $10.00 Price Target

    PALM BEACH, Fla., May 29, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that Sidoti & Company, LLC has initiated coverage of the company's common stock with a Not Rated (NR) classification and a price target of $10.00 per share. Sidoti is the third research firm to initiate coverage of Forum in 2026. The research report, authored by Brendan McCarthy, CFA, was published on May 28, 2026. Sidoti's initiation highlights Forum's position as an early mo

    5/29/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum to Present at Benchmark's Digital Assets Summit on May 27

    PALM BEACH, Fla., May 19, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that McAndrew Rudisill, chairman and CEO, and John Kristoff, senior vice president, corporate communications and investor relations, are expected to participate in the Benchmark Digital Assets Summit on Wednesday, May 27, 2026, in New York.  The company will participate in the panel discussion "How Tokenization Is Reshaping Private and Public Markets" at 3:00 PM EDT

    5/19/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Reports First Quarter 2026 Financial Results

    PALM BEACH, Fla., May 14, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today reported financial results for the first quarter ended March 31, 2026. "Forum continues to execute against our core strategy of building a platform centered on originating, structuring, and tokenizing institutional-grade, yield-generating assets," said McAndrew Rudisill, chairman and CEO. "We've expanded our origination capabilities with our entry into AI infr

    5/14/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Announces Initiation of Analyst Coverage by Clear Street

    Clear Street Initiates with Buy Rating and $11.00 Price TargetPALM BEACH, Fla., May 12, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced that Clear Street has initiated coverage of the company's common stock with a Buy rating and a price target of $11.00 per share. The research report, authored by Brian Dobson, Justin Pan, and Greg Pendy, was published on May 11, 2026. Clear Street's initiation highlights Forum's position as a regulated, public-marke

    5/12/26 3:16:00 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Announces First Quarter 2026 Earnings Release Date and Webcast Details

    PALM BEACH, Fla., April 30, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced it expects to release its financial results for the first quarter ended March 31, 2026, before the U.S. markets open on Thursday, May 14, 2026. McAndrew Rudisill, chairman and chief executive officer, and John Saunders, chief financial officer, will host a live webcast on the same day at 10:30 a.m. EDT, to discuss first quarter results and operational updates.To register and

    4/30/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FORUM PROVIDES UPDATE ON SHARE REPURCHASE PROGRAM

    PALM BEACH, Fla., April 29, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today provided an update on the status of its share repurchase program, which was reinitiated effective April 15, 2026, and announced publicly on April 17, 2026. Repurchase Activity to DateSince the reinitiation of the program, the Company has repurchased and cancelled an aggregate of approximately 5,647,351 shares of its common stock at an average price of approx

    4/29/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Board Reinitiates Share Repurchase Program; Forms Special Committee of Independent Directors to Evaluate Proposals to Maximize Shareholder Value

    PALM BEACH, Fla., April 17, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum", "the Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today announced a series of Board-authorized actions to maximize value for all shareholders. The Board and management team remain highly confident in Forum's business model, the long-term opportunity in tokenized real-world assets, and the Company's ability to generate revenue and cash flow as a standalone enterprise. At the same time, the Board believes it's in the best interest of shareholders to evaluate all opportunities to close the current gap between the Company's market

    4/17/26 8:30:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Announces Initiation of Analyst Coverage by Benchmark

    Benchmark Initiates with Speculative Buy Rating and $5.00 Price TargetPALM BEACH, Fla., April 7, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced that The Benchmark Company, LLC, a StoneX company, has initiated coverage of Forum's common stock with a Speculative Buy rating and a price target of $5.00 per share. The initiation, published by Benchmark analyst, Mark Palmer, on April 7, 2026, highlights Forum's position as a pure-play early m

    4/7/26 2:43:00 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Reports Fourth Quarter and Full Year 2025 Financial Results

    Company Introduces 2026 Guidance as RWA Tokenization Platform Begins to Scale PALM BEACH, Fla., March 31, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today reported financial results for the fourth quarter and full year ended December 31, 2025. "In less than a year, Forum has moved from concept to execution: from building the infrastructure, establishing key partnerships, and validating our technology, to generating revenu

    3/31/26 9:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum to Present at Sidoti's Small-Cap Virtual Investor Conference on March 18

    PALM BEACH, Fla., March 12, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum"), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced that McAndrew Rudisill, chairman and CEO, and John Kristoff, senior vice president, corporate communications and investor relations, are expected to participate in the Sidoti Small-Cap Virtual Investor Conference on Wednesday, March 18, 2026.  The company will participate in a group presentation at 2:30 PM EDT and will also host virtual one-on-one meeti

    3/12/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated SEC Filings

    View All

    Forum Markets Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    5/14/26 8:13:35 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/29/26 8:07:54 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/24/26 4:30:35 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form RW filed by Forum Markets Incorporated

    RW - FORUM MARKETS Inc (0001690080) (Filer)

    4/22/26 4:30:00 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/17/26 8:38:44 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Forum Markets Incorporated

    EFFECT - FORUM MARKETS Inc (0001690080) (Filer)

    4/10/26 12:15:03 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/8/26 9:06:39 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Forum Markets Incorporated

    424B3 - FORUM MARKETS Inc (0001690080) (Filer)

    4/8/26 8:29:06 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/8/26 8:10:40 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - FORUM MARKETS Inc (0001690080) (Filer)

    4/3/26 4:19:12 PM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated Leadership Updates

    Live Leadership Updates

    View All

    Forum Appoints Robert Spake as General Counsel

    PALM BEACH, Fla., March 3, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today announced the appointment of Robert Spake as the company's general counsel. Spake's deep legal expertise in capital markets, tokenization, and regulatory compliance strengthens Forum's leadership team and sharpens its focus on launching compliant, institutionally structured real-world asset products within evolving regulatory frameworks.  "Robert joins Forum at a pivotal mo

    3/3/26 9:00:00 AM ET
    $ETHZ
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Markets Incorporated Financials

    Live finance-specific insights

    View All

    Forum Reports First Quarter 2026 Financial Results

    PALM BEACH, Fla., May 14, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets, today reported financial results for the first quarter ended March 31, 2026. "Forum continues to execute against our core strategy of building a platform centered on originating, structuring, and tokenizing institutional-grade, yield-generating assets," said McAndrew Rudisill, chairman and CEO. "We've expanded our origination capabilities with our entry into AI infr

    5/14/26 8:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Forum Reports Fourth Quarter and Full Year 2025 Financial Results

    Company Introduces 2026 Guidance as RWA Tokenization Platform Begins to Scale PALM BEACH, Fla., March 31, 2026 /PRNewswire/ -- Forum Markets, Incorporated (NASDAQ:FRMM) ("Forum" or the "Company"), a digital asset platform modernizing capital markets through the tokenization of real-world assets on Ethereum, today reported financial results for the fourth quarter and full year ended December 31, 2025. "In less than a year, Forum has moved from concept to execution: from building the infrastructure, establishing key partnerships, and validating our technology, to generating revenu

    3/31/26 9:00:00 AM ET
    $FRMM
    Biotechnology: Pharmaceutical Preparations
    Health Care